CA910193A - Pharmaceutical compositions containing ergostine and caffeine - Google Patents

Pharmaceutical compositions containing ergostine and caffeine

Info

Publication number
CA910193A
CA910193A CA910193A CA910193DA CA910193A CA 910193 A CA910193 A CA 910193A CA 910193 A CA910193 A CA 910193A CA 910193D A CA910193D A CA 910193DA CA 910193 A CA910193 A CA 910193A
Authority
CA
Canada
Prior art keywords
ergostine
caffeine
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA910193A
Inventor
Berde Botond
Fanchamps Albert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Patent Ltd
Original Assignee
Sandoz Patent Ltd
Publication date
Application granted granted Critical
Publication of CA910193A publication Critical patent/CA910193A/en
Expired legal-status Critical Current

Links

CA910193A Pharmaceutical compositions containing ergostine and caffeine Expired CA910193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA910193T

Publications (1)

Publication Number Publication Date
CA910193A true CA910193A (en) 1972-09-19

Family

ID=36417824

Family Applications (1)

Application Number Title Priority Date Filing Date
CA910193A Expired CA910193A (en) Pharmaceutical compositions containing ergostine and caffeine

Country Status (1)

Country Link
CA (1) CA910193A (en)

Similar Documents

Publication Publication Date Title
CA1003752A (en) Pharmaceutical compositions
AU475493B2 (en) Pharmaceutical formulations
IL43722A0 (en) Novel 2-aminomethyleneindanones and pharmaceutical compositions containing them
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
AU475599B2 (en) Pharmaceutical compositions
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
AU5731773A (en) 2-oxo-indoline compounds and pharmaceutical compositions
IL43726A0 (en) Novel propanolamine derivatives and pharmaceutical compositions containing them
AU476390B2 (en) Pharmaceutical composition
AU464515B2 (en) Condensed bensopyran derivatives and pharmaceutical compositions containing them
ZA738187B (en) Pharmaceutical composition and preparation thereof
AU467532B2 (en) Pharmaceutical formulations
CA910193A (en) Pharmaceutical compositions containing ergostine and caffeine
AU5915973A (en) Pharmaceutical compositions
IL41564A0 (en) Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives
CA1006816A (en) Pharmaceutical compositions
CA986412A (en) Iodophor-steroid pharmaceutical compositions
CA905295A (en) Pharmaceutical compositions containing o-carbamyl-d-serine and cycloserine
AU477696B2 (en) Doxycyoline-containing pharmaceutical composition and preparation thereof
CA906405A (en) Drug glucuronides and compositions containing the same
CA904751A (en) Pharmaceutical compositions and their preparation
AU478574B2 (en) Pharmaceutical composition
CA900357A (en) Pharmaceutical composition
AU472192B2 (en) Pharmaceutical compositions
CA896528A (en) Pharmaceutical compositions